血管质量倡议中下肢血管疾病结局的地区差异
研究基于VQI 2009–2014年数据,分析15338例旁路和33925例腔内治疗的症状性PAD患者,比较16个地区的围术期和1年结局。结果显示不同地区在输血、截肢、心肌梗死和1年生存等方面存在显著差异,提示质量改进空间。
要点
- 旁路术后输血>2单位率地区间差异显著(跛行0%-13%,CLI 6.9%-27%)。
- CLI旁路术后1年生存率地区间85%-94%差异显著(P<.001)。
核心结论
- VQI各区域间PAD旁路或腔内治疗的围术期和1年结局存在显著差异。
研究设计与样本
- 回顾性队列研究,纳入VQI 2009–2014年15338例腹股沟下旁路和33925例腔内治疗的症状性PAD患者,按16个地区分组比较。
主要发现
- 旁路术后输血>2单位率地区间差异显著:跛行0.0%-13%(P<.001),CLI 6.9%-27%(P<.001)。
- CLI旁路术后院内大截肢率地区间0.0%-4.3%差异显著(P=.004),跛行旁路为0.0%-0.6%(P=.98)。
- CLI旁路术后 postoperative myocardial infarction 地区间0.8%-6%差异显著(P=.001),跛行旁路为0.0%-4%(P=.36)。
- 1年生存率地区间差异显著:跛行腔内治疗92%-100%(P<.001),CLI旁路85%-94%(P<.001),CLI腔内治疗77%-96%(P<.001)。
临床怎么用
- 区域质量改进组可利用本地区数据识别差异最大的结局指标并优先干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increased focus has been placed on perioperative and long-term outcomes in the treatment of peripheral artery disease (PAD), both for purposes of quality improvement and for assessment of performance at a surgeon and institutional level. This study evaluates regional variation in outcomes after treatment for PAD within the Vascular Quality Initiative (VQI). By describing the variation in practice patterns and outcomes across regions, we hope that each regionally based quality group can select which areas are most important for them to focus on as they will have access to their regional data to compare. METHODS: We identified all patients in the VQI who had infrainguinal bypass or endovascular intervention from 2009 to 2014. We compared variation in perioperative and 1-year outcomes stratified by symptom status and revascularization type among the 16 regional groups of the VQI. We analyzed variation in perioperative end points using χ2 analysis, and 1-year end points were analyzed using Kaplan-Meier and life-table analysis. RESULTS: We identified 15,338 bypass procedures for symptomatic PAD: 27% for claudication, 59% for chronic limb-threatening ischemia (CLI; 61% of these for tissue loss), and 14% for acute limb ischemia. We identified 33,925 endovascular procedures for symptomatic PAD: 42% for claudication, 48% for CLI (73% of these for tissue loss), and 10% for acute limb ischemia. Thirty-day mortality varied significantly after endovascular intervention for CLI (0.5%-3%; P < .001) but not for claudication (0.0%-0.5%, P = .77) or for bypass for claudication (0.0%-2.6%; P = .37) or CLI (0.0%-5.0%; P = .08). After bypass, rates of >2 units transfused red blood cells (claudication, 0.0%-13% [P < .001]; CLI, 6.9%-27% [P < .001]) varied significantly. In-hospital major amputation was variable after bypass for CLI (0.0%-4.3%; P = .004) but not for claudication (0.0%-0.6%; P = .98), as was postoperative myocardial infarction (claudication, 0.0%-4% [P = .36]; CLI, 0.8%-6% [P = .001]). One-year survival varied significantly for endovascular interventions for claudication (92%-100%; P < .001), bypass for CLI (85%-94% [P < .001]), and endovascular interventions for CLI (77%-96%; P < .001) but not after bypass for claudication (95%-100%; P = .57). CONCLUSIONS: In this real-world comparison among VQI regions, we found significant variation in perioperative and 1-year end points for patients with PAD undergoing bypass or endovascular intervention. This study highlights opportunities for quality improvement efforts to reduce variation and to improve outcomes.
引用
- Soden PA, Zettervall SL, Shean KE, et al. Regional variation in outcomes for lower extremity vascular disease in the Vascular Quality Initiative. J Vasc Surg. 2017. PMID: 28450103. doi:10.1016/j.jvs.2017.01.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。